Related Experiment Video
Updated: Aug 9, 2026
10:44
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Diurnal effects on debrisoquine hydroxylation phenotyping
1Department of Pharmacology, National University of Singapore.
European Journal of Clinical Pharmacology
|January 1, 1988
Summary
Debrisoquine phenotyping can be performed overnight. This study found good correlation between day and night metabolic ratios in most volunteers, suggesting a viable alternative method for drug metabolism studies.
Area of Science:
- Pharmacology
- Drug Metabolism
- Clinical Pharmacokinetics
Background:
- Debrisoquine phenotyping is crucial for assessing drug metabolism.
- Current phenotyping methods often require daytime administration and monitoring.
- Investigating alternative, less burdensome phenotyping procedures is warranted.
Purpose of the Study:
- To evaluate the feasibility of debrisoquine phenotyping as an overnight procedure.
- To compare day-time and night-time debrisoquine metabolic ratios.
- To determine the reliability of overnight phenotyping in normal volunteers.
Main Methods:
- Phenotyping was conducted on 33 normal volunteers.
- Debrisoquine administration and sample collection occurred both during the day and overnight.
- Metabolic ratios were calculated and compared between the two timeframes.
Main Results:
- A good correlation was observed between day-time and night-time metabolic ratios.
- The overnight procedure demonstrated comparable results to the day-time method for most participants.
- Significant variation was noted in 3 out of 33 subjects, requiring further investigation.
Conclusions:
- Overnight debrisoquine phenotyping is a feasible and reliable procedure for most individuals.
- This method offers a convenient alternative to traditional day-time phenotyping.
- Further research may be needed to understand the variability observed in a subset of subjects.
Related Concept Videos
01:19Factors Affecting Drug Biotransformation: Biological
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...